Skip to content

Development of quantitative evaluation of walking disability for neurodegenerative diseases using an infrared depth-sensing camera

Development of quantitative evaluation of walking disability for neurodegenerative diseases using an infrared depth-sensing camera - Quantitative evaluation of walking disability using an infrared depth-sensing camera

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025362
Enrollment
200
Registered
2016-12-21
Start date
2016-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinocerebellar degeneration, Multiple system atrophy,Amyotrophic lateral sclerosis,Parkinson&#39

Interventions

Walk analysis with an infrared depth-sensing camera(Spinocerebellar degeneration,Multiple system atrophy group):start time, 6 months, 12 months, 18 months, 24 months later. Walk analysis with an infra
s syndrome):start time, 6 months, 12 months, 18 months, 24 months later. Walk analysis with an infrared depth-sensing camera(normal control group):start time, 6 months, 12 months, 18 months, 24 months

Sponsors

Gunma University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Spinocerebellar degeneration: Probable 2 or higher according to the diagnostic criteria of Japan Intractable Diseases Information Center. Multiple system atrophy: probable or higher according to the diagnostic criteria of Multiple system atrophy. (Neurology 71:670-676, 2008) Amyotrophic lateral sclerosis: clinically probable-laboratory-supported ALS or higher according to the diagnostic criteria of El Escorial revised Airlie House. Parkinson's disease: Meet the diagnostic criteria of Japan Intractable Diseases Information Center. 2) Patients without gait disturbance.

Exclusion criteria

Exclusion criteria: 1) Patients with a history of intracranial disease and spinal cord disease other than the target disease. 2) Patients with sensory ataxia. 3) Patients judged inappropriate by the doctor.

Design outcomes

Primary

MeasureTime frame
Walk analysis with infrared depth-sensing camera (start time, 6 months, 12 months, 18 months, 24 months later)

Countries

Japan

Contacts

Public ContactSetsuki Tsukagoshi

Gunma University Graduate School of Medicine Department of Neurology

tukagos@gunma-u.ac.jp027-220-7111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026